Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium

The soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.

See how EV demand is creating new opportunities

SGMO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.60%

Insider Buying (Last 12 Months): $25,032.96

Insider Selling (Last 12 Months): $3,726,773.41

Sangamo Therapeutics Insider Trading History Chart

Sangamo Therapeutics Share Price & Price History

^$4.83

▼ -0.12 (-2.42%)

As of 09/26/2022 03:58 PM ET

Days: 30 | 90 | 365

Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium

From Investing Trends | Ad

See how EV demand is creating new opportunities

Sangamo Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/29/2022	Biogen Inc.	Major Shareholder	Sell	400,000	$5.33	$2,132,000.00	23,752,466
6/3/2022	John Markels	Director	Buy	6,784	$3.69	$25,032.96	32,484
12/27/2021	Biogen Inc.	Major Shareholder	Sell	600	$8.56	$5,136.00
12/23/2021	Biogen Inc.	Major Shareholder	Sell	81,187	$8.55	$694,148.85
12/9/2021	Biogen Inc.	Major Shareholder	Sell	23,660	$8.56	$202,529.60
12/7/2021	Biogen Inc.	Major Shareholder	Sell	52,178	$8.52	$444,556.56
11/26/2021	Biogen Inc.	Major Shareholder	Sell	28,884	$8.60	$248,402.40
3/23/2021	Gary Loeb	EVP	Sell	17,524	$13.13	$230,090.12
12/24/2020	Rolf Andrew Ramelmeier	EVP	Sell	3,331	$18.13	$60,391.03
12/17/2020	Saira Ramasastry	Director	Sell	10,000	$13.27	$132,700.00
3/18/2020	H Stewart Parker	Director	Buy	3,000	$5.20	$15,600.00
3/16/2020	Stephen George Dilly	Director	Sell	15,000	$6.02	$90,300.00
3/12/2020	Joseph S. Zakrzewski	Director	Buy	15,000	$6.31	$94,650.00

Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium

From Investing Trends | Ad

See how EV demand is creating new opportunities

SEC Filings (Institutional Ownership Changes) for Sangamo Therapeutics (NASDAQ:SGMO)

57.53% of Sangamo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sangamo Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/16/2022	Federated Hermes Inc.	729,350	$3.02M	0.0%	-32.7%	0.466%
9/13/2022	Brown Advisory Inc.	18,779	$78K	0.0%	+49.0%	0.012%
8/22/2022	ExodusPoint Capital Management LP	313,442	$1.30M	0.0%	N/A	0.200%
8/19/2022	Walleye Capital LLC	21,068	$87K	0.0%	-74.9%	0.013%
8/18/2022	Goldman Sachs Group Inc.	1,448,659	$6M	0.0%	+24.5%	0.925%
8/16/2022	Price T Rowe Associates Inc. MD	146,310	$0.61M	0.0%	+4.1%	0.093%
8/16/2022	Casdin Capital LLC	1,000,000	$4.14M	0.4%	N/A	0.639%
8/16/2022	Delphia USA Inc.	31,498	$0.13M	0.1%	+50.1%	0.020%
8/15/2022	State Street Corp	7,739,471	$32.04M	0.0%	-0.5%	4.944%
8/15/2022	PDT Partners LLC	64,876	$0.27M	0.0%	+25.8%	0.041%
8/15/2022	Point72 Hong Kong Ltd	28,019	$0.12M	0.0%	+1,081.7%	0.018%
8/15/2022	Cubist Systematic Strategies LLC	427,274	$1.77M	0.0%	+622.7%	0.273%
8/15/2022	Millennium Management LLC	1,206,252	$4.99M	0.0%	+74.7%	0.771%
8/15/2022	UBS Asset Management Americas Inc.	140,826	$0.58M	0.0%	+12.4%	0.090%
8/13/2022	Nordea Investment Management AB	681,112	$2.74M	0.0%	+5.0%	0.435%
8/13/2022	Teacher Retirement System of Texas	19,771	$82K	0.0%	-22.6%	0.013%
8/13/2022	Renaissance Technologies LLC	1,439,496	$5.96M	0.0%	+88.6%	0.919%
8/13/2022	American International Group Inc.	56,061	$0.23M	0.0%	-4.9%	0.036%
8/12/2022	Natixis	181,019	$0.75M	0.0%	N/A	0.116%
8/12/2022	Northern Trust Corp	1,165,831	$4.83M	0.0%	-2.8%	0.745%
8/12/2022	Virtus ETF Advisers LLC	31,424	$0.13M	0.0%	+49.8%	0.020%
8/12/2022	Credit Suisse AG	3,793,300	$15.70M	0.0%	+0.1%	2.423%
8/12/2022	Rafferty Asset Management LLC	310,056	$1.28M	0.0%	-36.9%	0.198%
8/12/2022	BNP Paribas Arbitrage SA	32,325	$0.13M	0.0%	-12.6%	0.021%
8/12/2022	Rhumbline Advisers	171,733	$0.71M	0.0%	+30.4%	0.110%
8/11/2022	UBS Group AG	197,616	$0.82M	0.0%	-57.1%	0.126%
8/11/2022	JPMorgan Chase & Co.	1,510,698	$6.25M	0.0%	+0.6%	0.965%
8/10/2022	Principal Financial Group Inc.	23,292	$97K	0.0%	-37.0%	0.016%
8/9/2022	Lazard Asset Management LLC	26,919	$0.11M	0.0%	+121.2%	0.018%
8/8/2022	Walleye Capital LLC	21,068	$87K	0.0%	-74.9%	0.014%
8/8/2022	Oppenheimer & Co. Inc.	76,600	$0.32M	0.0%	-35.3%	0.052%
8/8/2022	Banque Pictet & Cie SA	164,935	$0.68M	0.0%	-8.8%	0.112%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	386,126	$1.60M	0.0%	+237.5%	0.263%
8/4/2022	Vanguard Capital Wealth Advisors	17,780	$73K	0.1%	-46.7%	0.012%
8/4/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	62,874	$0.26M	0.0%	+86.3%	0.043%
8/3/2022	Janney Montgomery Scott LLC	43,745	$0.18M	0.0%	-20.7%	0.030%
8/3/2022	Handelsbanken Fonder AB	28,246	$0.12M	0.0%	-19.9%	0.019%
8/2/2022	Brown Advisory Inc.	18,779	$78K	0.0%	+49.0%	0.013%
8/1/2022	ProShare Advisors LLC	24,879	$0.10M	0.0%	-33.5%	0.017%
7/29/2022	SG Americas Securities LLC	123,707	$0.51M	0.0%	N/A	0.084%
7/29/2022	Russell Investments Group Ltd.	33,400	$0.14M	0.0%	N/A	0.023%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	553,727	$2.29M	0.0%	+44.1%	0.377%
7/25/2022	Allspring Global Investments Holdings LLC	7,760	$32K	0.0%	-90.1%	0.005%
7/25/2022	Strs Ohio	61,300	$0.25M	0.0%	+6.1%	0.042%
6/7/2022	Bank of America Corp DE	743,733	$4.32M	0.0%	+73.9%	0.507%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	384,393	$2.23M	0.0%	-15.6%	0.262%
5/27/2022	Walleye Capital LLC	83,973	$0.49M	0.0%	N/A	0.057%
5/20/2022	The Manufacturers Life Insurance Company	710,848	$4.13M	0.0%	-1.7%	0.485%
5/18/2022	BNP Paribas Arbitrage SA	36,971	$0.22M	0.0%	+51.1%	0.025%
5/18/2022	Golden State Equity Partners	154,360	$0.90M	0.4%	+7.4%	0.105%
5/17/2022	Walleye Capital LLC	83,973	$0.49M	0.0%	N/A	0.057%
5/17/2022	Royal Bank of Canada	32,948	$0.19M	0.0%	-33.9%	0.022%
5/17/2022	Delphia USA Inc.	20,983	$0.12M	0.1%	+44.5%	0.014%
5/17/2022	Dynamic Technology Lab Private Ltd	78,376	$0.46M	0.1%	N/A	0.053%
5/16/2022	California State Teachers Retirement System	155,424	$0.90M	0.0%	-7.8%	0.106%
5/16/2022	Goldman Sachs Group Inc.	1,163,887	$6.76M	0.0%	-4.4%	0.793%
5/16/2022	PDT Partners LLC	51,584	$0.30M	0.0%	+19.0%	0.035%
5/16/2022	State Street Corp	7,775,327	$45.18M	0.0%	+25.3%	5.301%
5/16/2022	Engineers Gate Manager LP	50,600	$0.29M	0.0%	+80.1%	0.034%
5/16/2022	Vident Investment Advisory LLC	17,814	$0.10M	0.0%	-17.0%	0.012%
5/16/2022	Invesco Ltd.	128,187	$0.74M	0.0%	+48.5%	0.087%
5/16/2022	UBS Group AG	460,380	$2.68M	0.0%	+12.7%	0.314%
5/16/2022	Hsbc Holdings PLC	15,914	$94K	0.0%	N/A	0.011%
5/13/2022	Rhenman & Partners Asset Management AB	761,429	$4.42M	0.4%	-0.5%	0.519%
5/13/2022	Renaissance Technologies LLC	763,096	$4.43M	0.0%	-10.3%	0.520%
5/13/2022	Northern Trust Corp	1,199,238	$6.97M	0.0%	-3.1%	0.818%
5/13/2022	Charles Schwab Investment Management Inc.	882,914	$5.13M	0.0%	+3.9%	0.602%
5/13/2022	Lazard Asset Management LLC	12,168	$70K	0.0%	+37.9%	0.008%
5/13/2022	Wasatch Advisors Inc.	10,576,997	$61.45M	0.3%	-3.5%	7.211%
5/13/2022	Penserra Capital Management LLC	11,376	$66K	0.0%	N/A	0.008%
5/13/2022	Federated Hermes Inc.	1,084,204	$6.30M	0.0%	+123.9%	0.739%
5/13/2022	American International Group Inc.	58,952	$0.34M	0.0%	-6.6%	0.040%
5/13/2022	Vanguard Group Inc.	10,135,861	$58.89M	0.0%	+8.5%	6.910%
5/13/2022	Dimensional Fund Advisors LP	2,840,893	$16.51M	0.0%	+27.6%	1.937%
5/12/2022	BlackRock Inc.	11,615,096	$67.49M	0.0%	-0.4%	7.919%
5/12/2022	Rhumbline Advisers	131,705	$0.77M	0.0%	-5.9%	0.090%
5/12/2022	Panagora Asset Management Inc.	199,945	$1.16M	0.0%	-66.8%	0.136%
5/12/2022	Metropolitan Life Insurance Co NY	8,069	$47K	0.0%	-73.3%	0.006%
5/12/2022	MetLife Investment Management LLC	59,668	$0.35M	0.0%	+33.9%	0.041%
5/12/2022	CI Investments Inc.	150,653	$0.88M	0.0%	N/A	0.103%
5/12/2022	E Fund Management Co. Ltd.	23,101	$0.13M	0.0%	+97.1%	0.016%
5/12/2022	AlphaCrest Capital Management LLC	14,419	$84K	0.0%	+25.4%	0.010%
5/12/2022	Citigroup Inc.	125,565	$0.73M	0.0%	-65.5%	0.086%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	114,414	$0.67M	0.0%	-17.8%	0.078%
5/12/2022	HighTower Advisors LLC	1,059,517	$6.17M	0.0%	+12.3%	0.722%
5/11/2022	Bank of New York Mellon Corp	443,190	$2.58M	0.0%	+0.9%	0.302%
5/11/2022	Raymond James Financial Services Advisors Inc.	92,792	$0.54M	0.0%	-24.5%	0.063%
5/11/2022	JPMorgan Chase & Co.	1,501,808	$8.73M	0.0%	-5.2%	1.024%
5/11/2022	GSA Capital Partners LLP	35,978	$0.21M	0.0%	N/A	0.025%
5/10/2022	ProShare Advisors LLC	37,394	$0.22M	0.0%	-19.5%	0.025%
5/10/2022	Aaron Wealth Advisors LLC	3,038	$0.52M	0.0%	N/A	0.002%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	384,393	$2.23M	0.0%	-15.6%	0.262%
5/9/2022	Swiss National Bank	292,760	$1.70M	0.0%	+8.4%	0.200%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	33,743	$0.20M	0.0%	+9.3%	0.023%
5/9/2022	Qube Research & Technologies Ltd	68,434	$0.40M	0.0%	N/A	0.047%
5/6/2022	Great Lakes Advisors LLC	523,194	$3.04M	0.0%	-19.8%	0.357%
5/6/2022	State Board of Administration of Florida Retirement System	62,445	$0.36M	0.0%	-33.2%	0.043%
5/4/2022	Advisor Group Holdings Inc.	23,897	$0.19M	0.0%	+12.7%	0.016%
5/4/2022	Commonwealth Equity Services LLC	23,006	$0.13M	0.0%	-27.7%	0.016%
5/4/2022	Banque Pictet & Cie SA	180,831	$1.05M	0.0%	+4.0%	0.123%

Data available starting January 2016

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.

Today's Range

Now: $4.83

$4.76

$5.06

50 Day Range

MA: $5.28

$4.27

$6.39

52 Week Range

Now: $4.83

$3.12

$11.49

Volume

55,732 shs

Average Volume

1,530,083 shs

Market Capitalization

$756.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Sangamo Therapeutics?: Sangamo Therapeutics' top insider shareholders include:
Biogen Inc (Major Shareholder)
John Markels (Director)
Gary Loeb (EVP)
Rolf Andrew Ramelmeier (EVP)
Saira Ramasastry (Director)
Learn More about top insider investors at Sangamo Therapeutics.
Who are the major institutional investors of Sangamo Therapeutics?: Sangamo Therapeutics' top institutional investors include:
State Street Corp — 4.94%
Credit Suisse AG — 2.42%
JPMorgan Chase & Co. — 0.96%
Goldman Sachs Group Inc. — 0.93%
Renaissance Technologies LLC — 0.92%
Millennium Management LLC — 0.77%
Learn More about top institutional investors of Sangamo Therapeutics stock.
Which major investors are selling Sangamo Therapeutics stock?: During the last quarter, SGMO stock was sold by these institutional investors:
Federated Hermes Inc.
UBS Group AG
Rafferty Asset Management LLC
Allspring Global Investments Holdings LLC
Walleye Capital LLC
Walleye Capital LLC
Oppenheimer & Co. Inc.
State Street Corp
Which major investors are buying Sangamo Therapeutics stock?: During the last quarter, SGMO stock was acquired by institutional investors including:
Casdin Capital LLC
Renaissance Technologies LLC
Millennium Management LLC
Cubist Systematic Strategies LLC
ExodusPoint Capital Management LP
Goldman Sachs Group Inc.
Connor Clark & Lunn Investment Management Ltd.
Natixis

Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium

From Investing Trends | Ad

See how EV demand is creating new opportunities

SGMO Insider Trading

Sangamo Therapeutics Insider Trading History Chart

Sangamo Therapeutics Share Price & Price History

Sangamo Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Sangamo Therapeutics (NASDAQ:SGMO)

Institutional Buying and Selling by Quarter

Sangamo Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Sangamo Therapeutics?

Who are the major institutional investors of Sangamo Therapeutics?

Which major investors are selling Sangamo Therapeutics stock?

Which major investors are buying Sangamo Therapeutics stock?